ITM Isotope Technologies Munich SE
General information
ITM Isotope Technologies Munich SE
Lichtenbergstrasse 1
85748 Garching / Munich, Bavaria
Germany
Contact person: Ben Orzelek, Head of Investor Relations & Treasury
Company main phone: +49 (89) 32989866000
Company main fax: +49 (89) 32989866061
Website: https://itm-radiopharma.com
Lichtenbergstrasse 1
85748 Garching / Munich, Bavaria
Germany
Contact person: Ben Orzelek, Head of Investor Relations & Treasury
Company main phone: +49 (89) 32989866000
Company main fax: +49 (89) 32989866061
Website: https://itm-radiopharma.com
| Year founded: | 2004 |
| Source of foundation: | Independent foundation |
Corporate description / mission:
ITM Isotope Technologies Munich, a radiopharmaceutical biotech company, is focused on developing new generation of radio molecular precision therapeutics and diagnostics for hard-to-treat tumours. Their programs are designed to address a range of cancers such as neuroendocrine tumours (“NETs”), prostate cancer, glioblastomas, folate receptor α (“FRα”)-positive tumours, such as ovarian cancer, or non-small cell lung (“NSCL”) adenocarcinoma and clear-cell renal cell carcinoma (“ccRCC”).
ITM Isotope Technologies Munich, a radiopharmaceutical biotech company, is focused on developing new generation of radio molecular precision therapeutics and diagnostics for hard-to-treat tumours. Their programs are designed to address a range of cancers such as neuroendocrine tumours (“NETs”), prostate cancer, glioblastomas, folate receptor α (“FRα”)-positive tumours, such as ovarian cancer, or non-small cell lung (“NSCL”) adenocarcinoma and clear-cell renal cell carcinoma (“ccRCC”).
State of ownership: Private / independent
Headquarters: HQ: Yes
Headquarters: HQ: Yes
Categorization
| Sector: |
|
| Subsector: |
|
| Primary therapeutic areas: |
|
| Business model: |
|
| Customer segments: |
|
| Distribution: |
|
Summary Products / Services / Technologies
Number of Biotech Products
| Pre-clinical: | 3 | |
| Phase I: | 7 | |
| Phase II: | 1 | |
| Phase III: | 3 |
Number of Medtech Products
| In development: | 5 |
Description of products:
ITM-11/ITM-14
ITM-91/ITM-94
ITM-63/ITM-64
ITM-23/ITM-24
ITM-51
ITM-24D, etc.
ITM-11/ITM-14
ITM-91/ITM-94
ITM-63/ITM-64
ITM-23/ITM-24
ITM-51
ITM-24D, etc.
Collaborations & Clients
Partnering strategy / collaborations:
The company is always seeking innovative drug discovery partnerships, ideally fusing their target know-how with their leading radioisotope platform technologies to develop next generation diagnostic and therapeutic agents that will help fight serious and difficult to treat cancer diseases.
The company is always seeking innovative drug discovery partnerships, ideally fusing their target know-how with their leading radioisotope platform technologies to develop next generation diagnostic and therapeutic agents that will help fight serious and difficult to treat cancer diseases.
© 2026 Biotechgate by Venture Valuation